Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Current Medical Research and Opinion|July 5, 2003
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazoleAndrew J UllmannCurrent Opinion in Infectious Diseases|November 1, 2006
Antifungal prophylaxis for invasive mycoses in high risk patientsAndrew J Ullmann, Oliver A CornelyWiener Medizinische Wochenschrift (1946)|July 13, 2004
[Current development in the diagnostics and therapy of systemic fungal infections in cancer patients]Meinolf Karthaus, Andrew J Ullmann, Oliver A CornelyMycoses|June 22, 2016
Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infectionsWerner J Heinz, Dieter Buchheidt, Andrew J UllmannWiener Medizinische Wochenschrift (1946)|July 13, 2004
[Opportunistic infections after treatment with monoclonal antibodies]Oliver A Cornely, Andrew J Ullmann, Meinolf KarthausWiener Medizinische Wochenschrift (1946)|July 13, 2004
[Vaccination of the immunocompromised host]Andrew J Ullmann, Meinolf Karthaus, Oliver A CornelyBlood|October 24, 2002
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignanciesOliver A Cornely, Andrew J Ullmann, Meinolf KarthausCurrent Opinion in Infectious Diseases|November 1, 2006
Is there a role for polyenes in treating invasive mycoses?Oliver A Cornely, Jörg-Janne Vehreschild, Andrew J UllmannAntimicrobial Agents and Chemotherapy|January 28, 2015
Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation studyOliver A Cornely, Angelika Böhme, Anne Schmitt-Hoffmann, et al.Pageof 8